Nurix Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Nurix Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
  • Nurix Therapeutics, Inc. Operating Lease, Payments for the quarter ending February 29, 2024 was $1.92M, a 38.2% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $8.32M, a 19.3% increase from 2023.
  • Nurix Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $6.97M, a 6.01% increase from 2022.
  • Nurix Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $6.58M, a 63.4% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.92M +$530K +38.2% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-10
Q1 2023 $1.39M +$71K +5.39% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-10
Q1 2022 $1.32M +$471K +55.7% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-13
Q1 2021 $846K Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.